Scope:

The scope of the CPG is intended to provide evidence on the effects of AFO or FES on: 

• Rehabilitation of individuals with acute and chronic stroke
• Goals based on a compensation and recovery approach
• Outcomes across the ICF levels of functioning

The target population of the CPG includes adults ( ≥18 years of age) of both genders and all races and ethnicities.

Publication:

The Journal of Neurologic Physical Therapy published the CPG in April 2021.

Resources:

     Podcast: ANPT Stroke SIG interview with Dr. Therese Johnston and Dr. Lisa Brown

CPG Quick Reference for Clinicians

Gait Analysis Quick Reference for Clinicians

Clinical Effects of an AFO/FES
Defining and applying the various effects of an AFO/FES to your patient 

Clinical Pearls Resource

Action Statement Evidence Summaries
Eight action statement evidence summary documents were designed for clinicians to briefly synthesize and summarize the evidence from the clinical practice guideline related to each action statement. They guide dosing for using AFO and FES, along with clinical pearls, to understand the patient-centered impact on their use.

NEW! Patient Education 

• The new AFO and FES fact sheet will help people working with physical therapists understand the differences between AFO and FES. The fact sheet describes the features and benefits of AFO and FES and how AFO or FES may help a person after a stroke.

AFO Types and AFO/FES Features: 

AFO Resources

• AFO Type: Benefits, considerations, and examples
• AFO Feature: Features that impact effects of an AFO

FES Resources

• FES: benefits, considerations, and examples

CPG Work Group